SplitApr 30, 2026, 06:41 AM
APRE Proposes Reverse Stock Split at 1:3 to 1:8 Ratio
AI Summary
Aprea Therapeutics, Inc. will hold its 2026 Annual Meeting of Stockholders virtually on June 16, 2026. Key proposals include the election of three Class I directors, the ratification of EisnerAmper LLP as the independent auditor, and the approval of an amendment to the Company's Certificate of Incorporation to authorize a reverse stock split of common stock. The proposed reverse stock split ratio is between one-for-three and one-for-eight, with the exact ratio and timing to be determined by the Board. Stockholders will also cast non-binding advisory votes on executive compensation and the frequency of future "say on pay" votes.
Key Highlights
- 2026 Annual Meeting of Stockholders to be held virtually on June 16, 2026.
- Proposal to elect three Class I directors for three-year terms.
- Proposal to ratify EisnerAmper LLP as independent auditor for fiscal year 2026.
- Proposal to approve a reverse stock split of common stock.
- Reverse stock split ratio proposed between one-for-three and one-for-eight.
- Board to determine exact ratio and timing for the reverse stock split.
- Advisory vote on named executive officer compensation.
- Advisory vote on frequency of future executive compensation votes.